Performance characteristics of an in-house assay system used to detect West Nile Virus (WNV)-specific immunoglobulin M during the 2001 WNV season in the United States.

PubWeight™: 1.39‹?› | Rank: Top 10%

🔗 View Article (PMC 145293)

Published in Clin Diagn Lab Immunol on January 01, 2003

Authors

Harry E Prince1, Wayne R Hogrefe

Author Affiliations

1: Focus Technologies, Cypress, California, 90630, USA. hprince@fousanswers.com

Articles citing this

Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34

Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol (2004) 1.76

Detection of West Nile virus (WNV)-specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States. Clin Diagn Lab Immunol (2003) 1.41

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol (2004) 1.11

Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation. J Clin Microbiol (2004) 1.06

Utility of the focus technologies west nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol (2004) 1.02

Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol (2005) 0.98

Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity. Clin Vaccine Immunol (2007) 0.85

Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska. Clin Vaccine Immunol (2006) 0.81